Manufacturer record
Biva Biotech: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Biva Biotech were declared Not of Standard Quality between May 2026 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Biva Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dextromethorphan Hydrobromide Chlorpheniramine Maleate Bromohexine Hydrobromide Syrup | AR651Mfg 2026-01 · Exp 2027-12 | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Rules 1945 with respect to Assay of Dextromethorphan Hydrobromide, and Chlorpheniramine Maleate.Assay | CDL, KolkataCDSCO lab | May 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.